Rodney Perkins Explained

Rodney Perkins (born 1936), a physician and entrepreneur, is Professor of Surgery at the Stanford School of Medicine.[1]

Biography

Born in 1936, Perkins grew up in Evansville, Indiana.[2] He attended Indiana University, initially enrolling as a dental student, but changed in his first year to pre-med, and then continued his studies at Indiana University School of Medicine. In his fourth year, as he was learning surgical procedures, he designed a medical device that cooled the blood prior to cardiac surgery that won first place in the AMA’s Medical Student Research Competition.[3] [4] He graduated in 1961. He works as a Neuro-Otologist in Woodside, California.

Academic career

Perkins moved to San Francisco in 1962 and one year later entered a surgical residency at Stanford University.[3] In 1968 he started his own practice adjacent to the Stanford campus.[5] This ultimately became the California Ear Institute at Stanford.[6] Perkins’ long tenure at Stanford was also celebrated with the dedication of the Rodney Perkins Microsurgery Laboratory in 2008.[7]

Business activities

Perkins’ research and career as an entrepreneur has mainly focused on the field of otology. He is the founder of the California Ear Institute at Stanford and a founder or cofounder of Soundhawk, Collagen Corporation,[8] Laserscope,[9] ReSound, Novacept, Pulmonx,[10] Sound ID,[11] EarLens,[12] and DFine Inc.[13] [14] Three of these companies have been taken public.[15] [16] [17]

Perkins is the founder of three public companies: Collagen Corporation (collagen-based implant materials),[3] Laserscope (surgical lasers),[9] and ReSound Corporation (high tech signal processing hearing devices).[17] He is also the founder and Chairman of Novacept (women's health), sold to Cytyc Corporation,[18] Sound ID (hearing science),[19] Pulmonx (interventional pulmonology and emphysema treatment),[20] and was Chairman of Surgrx (electrosurgical instrumentation), which was sold to Ethicon Endo-Surgery,[21] a division of Johnson & Johnson,[22] in 2008.

Currently, Perkins is founder, Director and CMO of Earlens Corporation, which is developing what it hopes will be a new method of sound transduction for hearing improvement.[23] Perkins is co-founder and Chairman of Procept,[24] a company developing a biorobotic minimally invasive solution for benign prostatic hypertrophy.[25]

Recognition

Perkins received the Lifetime Achievement Award from Medical Futures,[2] a British organization that fosters innovation in medicine. He also received the Distinguished Medical Alumnus Award from Indiana University and was inducted into the Evansville Hall of Fame.[26]

Notes and References

  1. Web site: Rodney Perkins, MD. Stanford. 12 December 2013.
  2. Web site: Professor Rodney Perkins Winner of a Medical Futures Lifetime Achievement Award. 16 December 2013.
  3. Web site: Fields. Helen. Biodesign series features innovations from Perkins. 16 December 2013.
  4. Web site: Three Indiana University Alumni to Receive Honors During Busy Reunion Weekend . 16 December 2013.
  5. Web site: CEI History.
  6. Web site: Dinner & Interview – Medical Insights. 16 December 2013.
  7. Web site: Microsurgery lab opens, named for Rodney Perkins. 16 December 2013.
  8. Web site: Fields. Helen. Biodesign series features innovations from Perkins. 12 December 2013.
  9. Web site: Laserscope History. 16 December 2013.
  10. Web site: Pulmonx Raises $32 Million for Launch of Emphysema Products. . 16 December 2013.
  11. Web site: About Sound ID. 16 December 2013.
  12. Web site: Board of Directors. 16 December 2013.
  13. Web site: Executive Profile Rodney Perkins M.D.. https://archive.today/20140110234037/http://investing.businessweek.com/research/stocks/private/person.asp?personId=1497405&privcapId=1470385. dead. January 10, 2014. 16 December 2013.
  14. Web site: Earlens Board of Directors. 16 December 2013.
  15. Web site: Collagen Corp Acquires Interest in Cohesion Corp. 16 December 2013.
  16. Web site: Laserscope History. 16 December 2013.
  17. Web site: ReSound Corporation Completes Offering of 2,500,000 Shares of Common Stock at $8.50 Per Share. 16 December 2013.
  18. Web site: Cytyc to acquire Novacept for $325M. 16 December 2013.
  19. Web site: Board of Directors. 16 December 2013.
  20. Web site: Ethicon Endo-Surgery To Acquire SurgRx. 16 December 2013.
  21. Web site: homepage. 16 December 2013.
  22. Web site: Ethicon homepage. 16 December 2013.
  23. Earlens tympanic contact transducer: a new method of sound transduction to the human ear. 8643293 . 114 . Otolaryngol Head Neck Surg. 720–8 . Perkins . R . 1996 . 6 . 10.1016/s0194-5998(96)70092-x.
  24. Web site: World First Surgery Robot Debuts at Tauranga Hospital. 16 December 2013.
  25. News: Dickison. Michael. Silicon Valley surgery robot debuts in NZ. 16 December 2013. The New Zealand Herald. Jan 25, 2013.
  26. News: Erbacher. Megan. EVSC inducts group into Hall of Fame. 16 December 2013.